Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.105
-0.055 (-1.74%)
May 13, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.01 billion as of May 14, 2026. Its market cap has increased by 34.53% in one year.
Market Cap
1.01B
Enterprise Value
431.88M
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.11
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.01B, a decrease of -81.64%. That is a compound annual growth rate of -23.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 1.01B | 28.73% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.79B |
| Thor Medical ASA | 1.59B |
| ArcticZymes Technologies ASA | 1.04B |
| Lytix Biopharma ASA | 811.30M |
| Zelluna ASA | 577.94M |
| SoftOx Solutions AS | 311.25M |
| Oncoinvent ASA | 218.10M |
| Arctic Bioscience AS | 88.96M |